Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts

J Neuroimmunol. 2007 Aug;188(1-2):48-55. doi: 10.1016/j.jneuroim.2007.05.003. Epub 2007 Jun 18.

Abstract

IL-10 is an anti-inflammatory cytokine that suppresses synthesis of proinflammatory cytokines and their receptors. Here we tested the possibility that TNFalpha-induced hormone resistance in myoblasts might be overcome by IL-10. We found that IL-10 restores myogenesis by suppressing the ability of exogenous TNFalpha to inhibit IGF-I-induced myogenin. This protection occurs without decreasing global activity of TNF receptors since IL-10 does not impair TNFalpha-induced IL-6 synthesis or ERK1/2 phosphorylation. Instead, IL-10 acts to prevent TNFalpha-induced phosphorylation of JNK. These findings demonstrate that IL-10 serves a previously unrecognized protective role in muscle progenitors by overcoming TNFalpha-induced resistance to IGF-I.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Cell Line
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Enzyme-Linked Immunosorbent Assay / methods
  • Gene Expression Regulation / drug effects
  • Immunologic Factors / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Interferon-alpha / pharmacology*
  • Interleukin-10 / pharmacology*
  • Interleukin-6 / metabolism
  • Mice
  • Mitogen-Activated Protein Kinases / metabolism
  • Myoblasts / drug effects*
  • Myogenin / metabolism

Substances

  • Immunologic Factors
  • Interferon-alpha
  • Interleukin-6
  • Myogenin
  • Interleukin-10
  • Insulin-Like Growth Factor I
  • Mitogen-Activated Protein Kinases